Solazyme, a US-based developer of biofuels through the use of algae, said it had raised $129.3m in equity and its strategic investors were Bunge, Chevron, Unilever and San-Ei Gen ahead of its $100m flotation.
Solazyme, a US-based developer of biofuels through the use of algae, plans to raise $100m through its flotation on the Nasdaq stock exchange.
The company said it had raised $129.3m in equity and its strategic investors were Bunge, Chevron, Unilever and San-Ei Gen, according to its regulatory filing.
Its other investors are family office Roda Group, investment bank Morgan Stanley and venture capital firms Braemar Energy Partners, Lightspeed Venture Partners, Harris and Harris Group, VantagePoint Venture Partners and…
